Evasion of Antiviral Immune Response and Improvement in Tumor-Specific Localization of Oncolytic Adenovirus by Hydrogel System

被引：0
|
作者：
Jung, Bo-Kyeong [1 ]
Oh, Eonju [1 ]
Hong, JinWoo [1 ]
Lee, Yunki [2 ]
Park, Ki Dong [2 ]
Yun, Chae-Ok [1 ]
机构：
[1] Hanyang Univ, Seoul, South Korea
[2] Ajou Univ, Suwon, South Korea
来源：
MOLECULAR THERAPY | 2018年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
725
引用
收藏
页码：332 / 332
页数：1
相关论文
共 50 条
  • [1] A hydrogel matrix prolongs persistence and promotes specific localization of an oncolytic adenovirus in a tumor by restricting nonspecific shedding and an antiviral immune response
    Jung, Bo-Kyeong
    Oh, Eonju
    Hong, JinWoo
    Lee, Yunki
    Park, Ki Dong
    Yun, Chae-Ok
    [J]. BIOMATERIALS, 2017, 147 : 26 - 38
  • [2] An oncolytic adenovirus redirected with a tumor-specific T cell
    Sebestyen, Zsolt
    de Vrij, Jeroen
    Magnusson, Maria
    Debets, Reno
    Willemsen, Ralph
    [J]. HUMAN GENE THERAPY, 2007, 18 (10) : 978 - 978
  • [3] An oncolytic adenovirus redirected with a tumor-specific T-Cell receptor
    Sebestyen, Zsolt
    de Vrij, Jeroen
    Magnusson, Maria
    Debets, Reno
    Willemsen, Ralph
    [J]. CANCER RESEARCH, 2007, 67 (23) : 11309 - 11316
  • [4] Tumor gangliosides inhibit the tumor-specific immune response
    McKallip, R
    Li, RX
    Ladisch, S
    [J]. JOURNAL OF IMMUNOLOGY, 1999, 163 (07): : 3718 - 3726
  • [5] Novel CpG-Rich Oncolytic Adenovirus Backbone To Stimulate Tumor-Specific Immune Response and Block the Suppression of Myeloid-Derived Suppressive Cells
    Cerullo, Vincenzo
    Diaconu, Iulia
    Romano, Valentina
    Ugolini, Matteo
    Rouvinen-Lagerstrom, Noora
    Escutenaire, Sophie
    Holm, Sirkka-Liisa
    Greco, Dario
    Hemminki, Akseli
    [J]. MOLECULAR THERAPY, 2012, 20 : S118 - S118
  • [6] Tumor-specific oncolytic adenovirus expressing trastuzumab antibody for treatment of HER2-positive cancer
    Liikanen, I.
    Guse, K.
    Gutmann, T.
    Savola, P.
    Tahtinen, S.
    Pesonen, S. K.
    Oksanen, M.
    Kanerva, A.
    Hemminki, A.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A92 - A92
  • [7] The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity
    Kleijn, Anne
    Kloezeman, Jenneke
    Treffers-Westerlaken, Elike
    Fulci, Giulia
    Leenstra, Sieger
    Dirven, Clemens
    Debets, Reno
    Lamfers, Martine
    [J]. PLOS ONE, 2014, 9 (05):
  • [8] Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy
    Saffarzadeh, Neshat
    Foord, Emelie
    O'Leary, Eoghan
    Mahmoun, Rand
    Hansen, Thomas Birkballe
    Levitsky, Victor
    Poiret, Thomas
    Uhlin, Michael
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [9] Tumor-specific oncolytic adenovirus coding for trastuzumab results in local production of functional monoclonal antibody from tumor cells
    Liikanen, Ilkka
    Savola, Paula
    Hemminki, Akseli
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [10] Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy
    Neshat Saffarzadeh
    Emelie Foord
    Eoghan O’Leary
    Rand Mahmoun
    Thomas Birkballe Hansen
    Victor Levitsky
    Thomas Poiret
    Michael Uhlin
    [J]. Journal of Translational Medicine, 22
12345